Cargando…

Multi-organ spatial stratification of 3-D dose distributions improves risk prediction of long-term self-reported severe symptoms in oropharyngeal cancer patients receiving radiotherapy: development of a pre-treatment decision support tool

PURPOSE: Identify Oropharyngeal cancer (OPC) patients at high-risk of developing long-term severe radiation-associated symptoms using dose volume histograms for organs-at-risk, via unsupervised clustering. MATERIAL AND METHODS: All patients were treated using radiation therapy for OPC. Dose-volume h...

Descripción completa

Detalles Bibliográficos
Autores principales: Wentzel, Andrew, Mohamed, Abdallah S. R., Naser, Mohamed A., van Dijk, Lisanne V., Hutcheson, Katherine, Moreno, Amy M., Fuller, Clifton D., Canahuate, Guadalupe, Marai, G. Elisabeta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442804/
https://www.ncbi.nlm.nih.gov/pubmed/37614495
http://dx.doi.org/10.3389/fonc.2023.1210087
_version_ 1785093680747511808
author Wentzel, Andrew
Mohamed, Abdallah S. R.
Naser, Mohamed A.
van Dijk, Lisanne V.
Hutcheson, Katherine
Moreno, Amy M.
Fuller, Clifton D.
Canahuate, Guadalupe
Marai, G. Elisabeta
author_facet Wentzel, Andrew
Mohamed, Abdallah S. R.
Naser, Mohamed A.
van Dijk, Lisanne V.
Hutcheson, Katherine
Moreno, Amy M.
Fuller, Clifton D.
Canahuate, Guadalupe
Marai, G. Elisabeta
author_sort Wentzel, Andrew
collection PubMed
description PURPOSE: Identify Oropharyngeal cancer (OPC) patients at high-risk of developing long-term severe radiation-associated symptoms using dose volume histograms for organs-at-risk, via unsupervised clustering. MATERIAL AND METHODS: All patients were treated using radiation therapy for OPC. Dose-volume histograms of organs-at-risk were extracted from patients’ treatment plans. Symptom ratings were collected via the MD Anderson Symptom Inventory (MDASI) given weekly during, and 6 months post-treatment. Drymouth, trouble swallowing, mucus, and vocal dysfunction were selected for analysis in this study. Patient stratifications were obtained by applying Bayesian Mixture Models with three components to patient’s dose histograms for relevant organs. The clusters with the highest total mean doses were translated into dose thresholds using rule mining. Patient stratifications were compared against Tumor staging information using multivariate likelihood ratio tests. Model performance for prediction of moderate/severe symptoms at 6 months was compared against normal tissue complication probability (NTCP) models using cross-validation. RESULTS: A total of 349 patients were included for long-term symptom prediction. High-risk clusters were significantly correlated with outcomes for severe late drymouth (p <.0001, OR = 2.94), swallow (p = .002, OR = 5.13), mucus (p = .001, OR = 3.18), and voice (p = .009, OR = 8.99). Simplified clusters were also correlated with late severe symptoms for drymouth (p <.001, OR = 2.77), swallow (p = .01, OR = 3.63), mucus (p = .01, OR = 2.37), and voice (p <.001, OR = 19.75). Proposed cluster stratifications show better performance than NTCP models for severe drymouth (AUC.598 vs.559, MCC.143 vs.062), swallow (AUC.631 vs.561, MCC.20 vs -.030), mucus (AUC.596 vs.492, MCC.164 vs -.041), and voice (AUC.681 vs.555, MCC.181 vs -.019). Simplified dose thresholds also show better performance than baseline models for predicting late severe ratings for all symptoms. CONCLUSION: Our results show that leveraging the 3-D dose histograms from radiation therapy plan improves stratification of patients according to their risk of experiencing long-term severe radiation associated symptoms, beyond existing NTPC models. Our rule-based method can approximate our stratifications with minimal loss of accuracy and can proactively identify risk factors for radiation-associated toxicity.
format Online
Article
Text
id pubmed-10442804
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-104428042023-08-23 Multi-organ spatial stratification of 3-D dose distributions improves risk prediction of long-term self-reported severe symptoms in oropharyngeal cancer patients receiving radiotherapy: development of a pre-treatment decision support tool Wentzel, Andrew Mohamed, Abdallah S. R. Naser, Mohamed A. van Dijk, Lisanne V. Hutcheson, Katherine Moreno, Amy M. Fuller, Clifton D. Canahuate, Guadalupe Marai, G. Elisabeta Front Oncol Oncology PURPOSE: Identify Oropharyngeal cancer (OPC) patients at high-risk of developing long-term severe radiation-associated symptoms using dose volume histograms for organs-at-risk, via unsupervised clustering. MATERIAL AND METHODS: All patients were treated using radiation therapy for OPC. Dose-volume histograms of organs-at-risk were extracted from patients’ treatment plans. Symptom ratings were collected via the MD Anderson Symptom Inventory (MDASI) given weekly during, and 6 months post-treatment. Drymouth, trouble swallowing, mucus, and vocal dysfunction were selected for analysis in this study. Patient stratifications were obtained by applying Bayesian Mixture Models with three components to patient’s dose histograms for relevant organs. The clusters with the highest total mean doses were translated into dose thresholds using rule mining. Patient stratifications were compared against Tumor staging information using multivariate likelihood ratio tests. Model performance for prediction of moderate/severe symptoms at 6 months was compared against normal tissue complication probability (NTCP) models using cross-validation. RESULTS: A total of 349 patients were included for long-term symptom prediction. High-risk clusters were significantly correlated with outcomes for severe late drymouth (p <.0001, OR = 2.94), swallow (p = .002, OR = 5.13), mucus (p = .001, OR = 3.18), and voice (p = .009, OR = 8.99). Simplified clusters were also correlated with late severe symptoms for drymouth (p <.001, OR = 2.77), swallow (p = .01, OR = 3.63), mucus (p = .01, OR = 2.37), and voice (p <.001, OR = 19.75). Proposed cluster stratifications show better performance than NTCP models for severe drymouth (AUC.598 vs.559, MCC.143 vs.062), swallow (AUC.631 vs.561, MCC.20 vs -.030), mucus (AUC.596 vs.492, MCC.164 vs -.041), and voice (AUC.681 vs.555, MCC.181 vs -.019). Simplified dose thresholds also show better performance than baseline models for predicting late severe ratings for all symptoms. CONCLUSION: Our results show that leveraging the 3-D dose histograms from radiation therapy plan improves stratification of patients according to their risk of experiencing long-term severe radiation associated symptoms, beyond existing NTPC models. Our rule-based method can approximate our stratifications with minimal loss of accuracy and can proactively identify risk factors for radiation-associated toxicity. Frontiers Media S.A. 2023-08-08 /pmc/articles/PMC10442804/ /pubmed/37614495 http://dx.doi.org/10.3389/fonc.2023.1210087 Text en Copyright © 2023 Wentzel, Mohamed, Naser, van Dijk, Hutcheson, Moreno, Fuller, Canahuate and Marai https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Wentzel, Andrew
Mohamed, Abdallah S. R.
Naser, Mohamed A.
van Dijk, Lisanne V.
Hutcheson, Katherine
Moreno, Amy M.
Fuller, Clifton D.
Canahuate, Guadalupe
Marai, G. Elisabeta
Multi-organ spatial stratification of 3-D dose distributions improves risk prediction of long-term self-reported severe symptoms in oropharyngeal cancer patients receiving radiotherapy: development of a pre-treatment decision support tool
title Multi-organ spatial stratification of 3-D dose distributions improves risk prediction of long-term self-reported severe symptoms in oropharyngeal cancer patients receiving radiotherapy: development of a pre-treatment decision support tool
title_full Multi-organ spatial stratification of 3-D dose distributions improves risk prediction of long-term self-reported severe symptoms in oropharyngeal cancer patients receiving radiotherapy: development of a pre-treatment decision support tool
title_fullStr Multi-organ spatial stratification of 3-D dose distributions improves risk prediction of long-term self-reported severe symptoms in oropharyngeal cancer patients receiving radiotherapy: development of a pre-treatment decision support tool
title_full_unstemmed Multi-organ spatial stratification of 3-D dose distributions improves risk prediction of long-term self-reported severe symptoms in oropharyngeal cancer patients receiving radiotherapy: development of a pre-treatment decision support tool
title_short Multi-organ spatial stratification of 3-D dose distributions improves risk prediction of long-term self-reported severe symptoms in oropharyngeal cancer patients receiving radiotherapy: development of a pre-treatment decision support tool
title_sort multi-organ spatial stratification of 3-d dose distributions improves risk prediction of long-term self-reported severe symptoms in oropharyngeal cancer patients receiving radiotherapy: development of a pre-treatment decision support tool
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442804/
https://www.ncbi.nlm.nih.gov/pubmed/37614495
http://dx.doi.org/10.3389/fonc.2023.1210087
work_keys_str_mv AT wentzelandrew multiorganspatialstratificationof3ddosedistributionsimprovesriskpredictionoflongtermselfreportedseveresymptomsinoropharyngealcancerpatientsreceivingradiotherapydevelopmentofapretreatmentdecisionsupporttool
AT mohamedabdallahsr multiorganspatialstratificationof3ddosedistributionsimprovesriskpredictionoflongtermselfreportedseveresymptomsinoropharyngealcancerpatientsreceivingradiotherapydevelopmentofapretreatmentdecisionsupporttool
AT nasermohameda multiorganspatialstratificationof3ddosedistributionsimprovesriskpredictionoflongtermselfreportedseveresymptomsinoropharyngealcancerpatientsreceivingradiotherapydevelopmentofapretreatmentdecisionsupporttool
AT vandijklisannev multiorganspatialstratificationof3ddosedistributionsimprovesriskpredictionoflongtermselfreportedseveresymptomsinoropharyngealcancerpatientsreceivingradiotherapydevelopmentofapretreatmentdecisionsupporttool
AT hutchesonkatherine multiorganspatialstratificationof3ddosedistributionsimprovesriskpredictionoflongtermselfreportedseveresymptomsinoropharyngealcancerpatientsreceivingradiotherapydevelopmentofapretreatmentdecisionsupporttool
AT morenoamym multiorganspatialstratificationof3ddosedistributionsimprovesriskpredictionoflongtermselfreportedseveresymptomsinoropharyngealcancerpatientsreceivingradiotherapydevelopmentofapretreatmentdecisionsupporttool
AT fullercliftond multiorganspatialstratificationof3ddosedistributionsimprovesriskpredictionoflongtermselfreportedseveresymptomsinoropharyngealcancerpatientsreceivingradiotherapydevelopmentofapretreatmentdecisionsupporttool
AT canahuateguadalupe multiorganspatialstratificationof3ddosedistributionsimprovesriskpredictionoflongtermselfreportedseveresymptomsinoropharyngealcancerpatientsreceivingradiotherapydevelopmentofapretreatmentdecisionsupporttool
AT maraigelisabeta multiorganspatialstratificationof3ddosedistributionsimprovesriskpredictionoflongtermselfreportedseveresymptomsinoropharyngealcancerpatientsreceivingradiotherapydevelopmentofapretreatmentdecisionsupporttool